Home > Insider Trading > Filing (0001209191-12-011830)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1347178	Vanda Pharmaceuticals Inc.	VNDA	Pharmaceutical Preparations (2834)	030491827

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1506314	Patrick James Kelly	9605 Medical Center Drive Suite 300 Rockville MD 20850	Svp, Cfo, Sec & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-16	12,500	$0.00	17,500	No	4	M	Direct
Common Stock	Disposition	2012-02-16	4,920	$4.67	12,580	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2012-02-16	12,500	$0.00	12,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,500			No	4	M	Direct

Footnotes

Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
This transaction was executed in multiple trades at prices ranging from $4.63 to $4.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
The Restricted Stock Units vest in four equal annual installments beginning January 1, 2012. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
N/A